Early research (Phase 1)Study completedNCT02583464
What this trial is testing
Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.
Who this might be right for
Acquired Immunodeficiency Syndrome
Laboratorio Elea Phoenix S.A. 24